Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 29, 2013, Pages 11970-11975

  Marras, Francesco ^a   Nicco, Elena ^b   Bozzano, Federica ^b   Di Biagio, Antonio ^b,c   Dentone, Chiara ^d   Pontali, Emanuele ^e   Boni, Silvia ^f   Setti, Maurizio ^c,h   Orofino, Giancarlo ^h   Mantia, Eugenio ⁱ   Bartolacci, Valentina ^j   Bisio, Francesca ^a   Riva, Agostino ^k   Biassoni, Roberto ^a   Moretta, Lorenzo ^a   De Maria, Andrea ^b,c,g  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d Ospedale di Sanremo   (Italy)

^e GALLIERA HOSPITAL   (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g UNIVERSITY OF GENOA   (Italy)

^h AMEDEO DI SAVOIA HOSPITAL   (Italy)

ⁱ Unità di Malattie Infettive   (Italy)

^j Azienda Sanitaria Locale n2   (Italy)

^k UNIVERSITY OF MILAN   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR NKG2D;

ARTICLE; CELL ACTIVATION; CELL MATURATION; CLINICAL ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; VIREMIA; VIRUS LOAD; VIRUS REPLICATION;

ANTIBODIES, MONOCLONAL; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HUMANS; IMMUNITY, INNATE; IMMUNOPHENOTYPING; INTERLEUKIN-2; KILLER CELLS, NATURAL; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; STATISTICS, NONPARAMETRIC;

EID: 84880351147     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1302090110     Document Type: Article

References (52)

1. O'Connell KA, Bailey JR, Blankson JN (2009) Elucidating the elite: Mechanisms of control in HIV-1 infection. Trends Pharmacol Sci 30(12):631-637.
2. Poropatich K, Sullivan DJ, Jr. (2011) Human immunodeficiency virus type 1 long-term non-progressors: The viral, genetic and immunological basis for disease non-progression. J Gen Virol 92(Pt 2):247-268.
3. Lamine A, et al. (2007) Replication-competent HIV strains infect HIV controllers despite undetectable viremia (ANRS EP36 study). AIDS 21(8):1043-1045.
4. Blankson JN, et al. (2007) Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors. J Virol 81(5): 2508-2518.
5. Miura T, et al. (2008) Genetic characterization of human immunodeficiency virus type 1 in elite controllers: Lack of gross genetic defects or common amino acid changes. J Virol 82(17):8422-8430.
6. Geldmacher C, et al. (2007) CD8 T-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patients. J Virol 81(5): 2440-2448.
7. Migueles SA, et al. (2000) HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci USA 97(6):2709-2714.
8. Fellay JSK, et al. (2007) A whole-genome association study of major determinants for host control of HIV-1. Science 317(5840):944-947.
9. Emu B, et al. (2008) HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control. J Virol 82(11):5398-5407.
10. Mothe B, et al. (2012) CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control. PLoS ONE 7(1):e29717.
11. Tomescu C, et al. (2012) Impact of protective killer inhibitory receptor/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers. AIDS 26(15):1869-1878.
12. Mendoza D, et al. (2012) HLA B*5701-positive long-term nonprogressors/elite controllers are not distinguished from progressors by the clonal composition of HIVspecific CD8+ T cells. J Virol 86(7):4014-4018.
13. Martin MP, et al. (2007) Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 39(6):733-740.
14. Martin MP, et al. (2002) Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 31(4):429-434.
15. Alter G, et al. (2007) Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med 204(12):3027-3036.
16. O'Connell KA, Han Y, Williams TM, Siliciano RF, Blankson JN (2009) Role of natural killer cells in a cohort of elite suppressors: Low frequency of the protective KIR3DS1 allele and limited inhibition of human immunodeficiency virus type 1 replication in vitro. J Virol 83(10):5028-5034.
17. De Maria A, et al. (2003) The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur J Immunol 33(9):2410-2418.
18. Mavilio D, et al. (2006) Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection. J Exp Med 203(10): 2339-2350.
19. Bozzano F, et al. (2011) NK-cell phenotype at interruption underlies widely divergent duration of CD4+-guided antiretroviral treatment interruption. Int Immunol 23(2): 109-118.
20. Rutjens E, et al. (2007) Differential NKp30 inducibility in chimpanzee NK cells and conserved NK cell phenotype and function in long-term HIV-1-infected animals. J Immunol 178(3):1702-1712.
21. Bozzano F, et al. (2011) Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment. Eur J Immunol 41(10):2905-2914.
22. Stegmann KA, et al. (2012) Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1. J Infect Dis 205(9):1351-1362.
23. Vitale M, et al. (2005) NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood 106(2):566-571.
24. Pende D, et al. (2006) Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: Relevance for natural killer-dendritic cell interaction. Blood 107(5):2030-2036.
25. Ward J, et al. (2007) HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts. Blood 110(4): 1207-1214.
26. Cerboni C, et al. (2007) Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity. J Gen Virol 88(Pt 1):242-250.
27. Matusali G, Potestà M, Santoni A, Cerboni C, Doria M (2012) The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cellactivating ligand PVR. J Virol 86(8):4496-4504.
28. Fausther-Bovendo H, Vieillard V, Sagan S, Bismuth G, Debré P (2010) HIV gp41 engages gC1qR on CD4+ T cells to induce the expression of an NK ligand through the PIP3/H2O2 pathway. PLoS Pathog 6(7):e1000975.
29. Vieillard V, Strominger JL, Debré P (2005) NK cytotoxicity against CD4+ T cells during HIV-1 infection: A gp41 peptide induces the expression of an NKp44 ligand. Proc Natl Acad Sci USA 102(31):10981-10986.
30. Moretta L (2010) Dissecting CD56dim human NK cells. Blood 116(19):3689-3691.
31. Lopez-Vergès S, et al. (2010) CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood 116(19):3865-3874.
32. Björkström NK, et al. (2010) Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 116(19):3853-3864.
33. De Maria A, Bozzano F, Cantoni C, Moretta L (2011) Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation. Proc Natl Acad Sci USA 108(2):728-732.
34. Vankayalapati R, et al. (2004) NK cells regulate CD8+ T cell effector function in response to an intracellular pathogen. J Immunol 172(1):130-137.
35. Warfield KL, et al. (2004) Role of natural killer cells in innate protection against lethal ebola virus infection. J Exp Med 200(2):169-179.
36. Moretta A (2002) Natural killer cells and dendritic cells: Rendezvous in abused tissues. Nat Rev Immunol 2(12):957-964.
37. Marras F, Bozzano F, De Maria A (2011) Involvement of activating NK cell receptors and their modulation in pathogen immunity. J Biomed Biotechnol 2011(2011): 152430.
38. De Maria A, et al. (1997) Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: Impairment of specific cytolytic functions. Proc Natl Acad Sci USA 94(19):10285-10288.
39. Costa P, et al. (2001) Differential disappearance of inhibitory natural killer cell receptors during HAART and possible impairment of HIV-1-specific CD8 cytotoxic T lymphocytes. AIDS 15(8):965-974.
40. Fogli M, et al. (2004) Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1-infected patients. Eur J Immunol 34(8): 2313-2321.
41. Lichtfuss GF, et al. (2012) Virologically suppressed HIV patients show activation of NK cells and persistent innate immune activation. J Immunol 189(3):1491-1499.
42. Björkström NK, et al. (2010) Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 116(19):3853-3864.
43. Miura T, et al. (2009) HLA-Associated viral mutations are common in human immunodeficiency virus type 1 elite controllers. J Virol 83(7):3407-3412.
44. Miura T, et al. (2009) HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition. J Virol 83(6): 2743-2755.
45. Sajadi MM, Pulijala R, Redfield RR, Talwani R (2012) Chronic immune activation and decreased CD4 cell counts associated with hepatitis C infection in HIV-1 natural viral suppressors. AIDS 26(15):1879-1884.
46. Pereyra F, et al. (2012) Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers. AIDS 26(18):2409-2412.
47. FogliM, et al. (2008) Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals. PLoS Pathog 4(7): E1000101.
48. Curriu M, et al. (2012) Viremic HIV infected individuals with high CD4 T cells and functional envelope proteins show anti-gp41 antibodies with unique specificity and function. PLoS One 7(2):e30330.
49. Vieillard V, Dereuddre-Bosquet N, Mangeot-Méderlé I, Le Grand R, Debré P (2012) An HIVgp41 vaccine protects CD4 central memory T cells in SHIV-infected macaques. Vaccine 30(48):6883-6891.
50. De Maria A, et al. (2007) Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients. Eur J Immunol 37(2):445-455.
51. Lee-MacAry AE, et al. (2001) Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide. J Immunol Methods 252(1-2):83-92.
52. Ferlazzo G, et al. (2003) The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells. Eur J Immunol 33(2):306-313.